ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,396.06
      -0.60%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Day One Biopharmaceuticals Inc (DAWN)

      7. Day One Biopharmaceuticals Inc (DAWN) News

      Day One Biopharmaceuticals Inc

      Day One Biopharmaceuticals Inc (DAWN)

      NASDAQ
      16.03
      0.15
      (0.94%)
      Closed July 28 4:00PM
      Delayed by 15 minutes
      16.01
      -0.02
      (-0.12%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      DAWN News

      Official News Only

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      May 14 2024
      DAWN (0.94%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      May 06 2024
      DAWN (0.94%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      May 06 2024
      DAWN (0.94%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      March 07 2024
      DAWN (0.94%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 28 2024
      DAWN (0.94%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      February 27 2024
      DAWN (0.94%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 20 2024
      DAWN (0.94%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 20 2024
      DAWN (0.94%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      February 16 2024
      DAWN (0.94%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      January 17 2024
      DAWN (0.94%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 09 2024
      DAWN (0.94%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 09 2024
      DAWN (0.94%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      January 08 2024
      DAWN (0.94%)

      Form S-8 - Securities to be offered to employees in employee benefit plans
      Edgar (US Regulatory)
      January 04 2024
      DAWN (0.94%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 17 2023
      DAWN (0.94%)

      DAWN Discussion

      View Posts

      Your Recent History

      NASDAQ
      DAWN
      Day One Biopharmaceuticals
      Delayed Upgrade Clock